The first two Healing Stories feature frontline healthcare workers who found relief through ketamine-assisted psychotherapy (KAP) when the stress of the pandemic destabilized their mental health and exacerbated pre-existing conditions. Whether they see their own experiences reflected or those of their loved ones, we hope that Healing Stories will resonate and empower people to reach out for help.”
Yaron Conforti, CEO and Director, commented, “We know one of the most powerful ways to break down stigma is through sharing lived experiences. While promising data from clinical research and advocacy supported by Novamind and other mission-driven organizations continues to increase awareness and public education, negative perceptions of mental health conditions are frequently cited as a barrier to seeking help. Healing Stories was commissioned by Novamind as part of the Company’s ongoing efforts to destigmatize mental illness and to educate the public on psychedelic medicine.
#Novamind inc series#
TORONTO, ON / ACCESSWIRE / Febru/ Novamind Inc.(CSE:NM)(OTCQB:NVMDF)(FSE:HN2) (“Novamind” or the “Company”), a leading mental health company specialized in psychedelic medicine, today launched Healing Stories, a series of case studies with first-hand accounts of patient experiences with psychedelic-assisted psychotherapy at Novamind clinics (“Healing Stories”).
0 kommentar(er)
